4Life Transfer Factor® Products Included in 2013 Physicians’ Desk Reference
Salt Lake City, Utah
(January 8, 2013) 4Life executives are pleased to
announce that 4Life Transfer Factor® products are listed
in the 2013 Physician’s Desk Reference (PDR).
4Life Transfer Factor® Products Approved for Use by Olympic Athletes
Salt Lake City, Utah (December 4, 2007)
As first reported by 4Life Chief Scientific
Officer Calvin McCausland, Ph.D., in Direct
Selling News, 4Life received documentation
from the Federal Anti-Doping Center in
Moscow, Russia, that admits 4Life Transfer
Factor for use by Olympians in practice,
training, and competition. Approval was
obtained after volunteers consumed 4Life
Transfer Factor products and their bodily
fluids were analyzed in accordance with
doping control procedures that employ modern
methods of gas chromatography and
mass-spectrometry in compliance with the
World Anti-Doping Agency in Montreal,
4Life Research Announces New Discovery
September 21, 2007 (Salt Lake City, Utah) 4Life Research™, the world leader in Transfer Factor science and immune system support development, announced today the discovery of immune activity in a weight range of molecules significantly smaller than transfer factors.
Transfer factors are molecules in a weight class between 3,500 - 12,000 daltons that help the immune system recognize, respond to, and remember outside threats. Although scientists have known that smaller molecules than transfer factors existed within cow colostrum, their significance in terms of immune activity has been unknown until now.
In 2005, 4Life Chief Executive Officer David Lisonbee and the Research and Development department began studying these low weight molecules. After two years of research, 4Life clinical findings now indicate that molecules in a weight range between 250 — 3,000 daltons play important regulatory roles in the immune system.
4Life extracted and concentrated these nanofraction molecules from cow colostrum for their proprietary NanoFactor™ extract, combining NanoFactor with their exclusive Transfer Factor E-XF™ extract of transfer factors from cow colostrum and chicken egg yolks to produce 4Life Transfer Factor® Tri-Factor™ Formula, the most comprehensive approach to immune system support available today.
"I don't know of another company in our category," said 4Life Chief Scientific Officer Calvin McCausland, Ph.D. "In 2004, we were the first company to combine transfer factors from cow colostrum and chicken egg yolks. In 2005, we introduced RioVida®, the world's only transfer factor beverage. Now, the discovery of new immune activity in nanofractions. When it comes to scientific innovation, there's simply no comparison to 4Life."
4Life Transfer Factor, Transfer Factor Plus®, and RioVida are now fortified with the new Tri-Factor Formula. "We're taking Tri-Factor Formula to the world because no other product represents such a unique and indispensable opportunity for a quality life," remarked 4Life President Steve Tew.
David Lisonbee: "At the end of the day, our distributors can rest assured that 4Life will stay a good pace ahead of the curve in the areas of science, service, and success."
4Life, global leader in the development, production, and distribution of Transfer Factor immune support products, continues to post growth in more than 40 countries around the world.
4Life® Transfer Factor™ Now Approved By the Health Ministry of Russia for use in Hospitals and Clinics!
First Ever Dietary Supplement to be Approved for Use by Doctors and Hospitals in Russia
SANDY, UT (October 1, 2004) - In an unprecedented announcement in the history of network marketing, 4Life announced today that 4Life Transfer Factor products as immune modulators have been approved for use in hospitals and clinics in the Russian Federation. The results of ten separate clinical trials and two experimental studies on 4Life Transfer Factor products were combined in a Methodological Document that was approved by the Ministry of Health, which now allows doctors to recommend 4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their patients.
First Dietary Supplement Approved for Use by Doctors and Hospitals in Russia
Commenting on this remarkable achievement, David Lisonbee, CEO of 4Life stated, “To my knowledge, this is the first time in the history of this industry that a network marketing company or any other dietary supplement company has had one of its dietary supplements approved for use in hospitals in Russia. The Russian Ministry of Health is the equivalent of the Food and Drug Administration in the United States. Doctors and scientists from Russia have been working jointly with scientists from 4Life for several years to arrive at this accomplishment. This approval establishes a new roll of dietary supplements in the Russian health care system.
Remarkable Response from Russian Academy of Medical Sciences
In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian Academy of Medical Sciences stated, “The 4Life sample [Transfer Factor Advanced Formula] activated NK (natural killer) cell activity more than the Interleukin-2 (IL2) drug we used as the standard.” This discovery has attracted the attention of The International Scientific and Technical Center (ISTC) of Russia.
Scientists from Several Countries Join Forces for Additional Clinical Studies of Transfer Factor
The ISTC of Russia is a member of a joint international project with other health agencies of Japan, Europe and the US. The objective of the international project is to combine efforts in finding improved immunotherapies. Following the discoveries from the NK cell testing, the scientists of 4Life have been invited to join the project. 4Life Transfer Factor as an immune modulator will be further researched in this international forum. The cost of the studies will be paid by the ISTC.
Speaking of this benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life, and Dr. Emma Oganova, 4Life/Eurasia President, jointly expressed that because of the acceptance by such a reputable organization and doctors from Russia and other major countries, 4Life Transfer Factor will gain wider acceptance in the professional and private sectors as a superior immune system enhancing product. The worldwide ramifications to this acceptance are just beginning.
4Life Research is the World’s foremost leader in the development, production and distribution of natural immune support products and was recently recognized by Inc. magazine as the fifteenth fastest growing privately-held company in America.
Transfer Factor | Riovida | Company | Clinical Studies | TF & NK Cells | Related Links | Products | How To Order | TF & Pets | Testimonials | FAQ | Biz Opportunity | Contact Us